HDAC9 and breast cancer: The triterpenoid TCD exhibited antiproliferative effect on breast cancer accompanied with induction of apoptosis, down-regulation of Akt-NF-κB signaling, activation of p53 phosphorylation, increased ROS generation and HDAC inhibition.